Accelerating the Flow of Innovation from Bench to Bedside.

Our Story

While U.S. research universities and medical centers continue to lead the world in biomedical innovation, there is a well-acknowledged gap between basic science and the development of real world products – a schism between the bench and the bedside. This gap is caused by a lack of access to the know-how and funding required to validate an innovation’s technical feasibility and commercial relevance, both of which are essential for translating promising discoveries into well-defined product opportunities that are attractive to the commercial ecosystem. Bridging this translational development gap requires a tailored business model that is outside the scope of what venture investors, academic institutions, and the biopharma industry are set up to do.

The IBE brings the specialized know-how and the funding required for translational development success. In addition, the IBE provides biomedical researchers and innovators with educational programs and hands-on training that will help them become more aware of how to make their discoveries end up in the marketplace.